[1]崔晋伟 张晓梅,杨华升 赖宇鑫 刘彧杉 于小林 姜良铎.姜良铎从急性虚损辨治新型冠状病毒肺炎探讨[J].陕西中医药大学学报,2021,44(01):010-14.[doi:10.13424/j.cnki.jsctcm.2021.01.002]
　CUI Jin - wei,ZHANG Xiao - mei,YANG Hua - sheng,et al.Discussion on the Treatment of COVID-19 from the Pespective of Acute Insufficiency Differentiation Syndrome by JIANG Liang-duo[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(01):010-14.[doi:10.13424/j.cnki.jsctcm.2021.01.002]
点击复制

姜良铎从急性虚损辨治新型冠状病毒肺炎探讨()
分享到：

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
44
期数:
2021年01期
页码:
010-14
栏目:
出版日期:
2021-01-30

文章信息/Info

Title:
Discussion on the Treatment of COVID-19 from the Pespective of Acute Insufficiency Differentiation Syndrome by JIANG Liang-duo
文章编号:
2096-1340(2021)01-0010-05
作者:
崔晋伟1 张晓梅2; 杨华升3 赖宇鑫1 刘彧杉1 于小林1 姜良铎4
1.北京中医药大学,北京 100029;
2.北京中医药大学东方医院,北京 100078;
3.首都医科大学附属佑安医院, 北京 100069;4.北京中医药大学东直门医院,北京 100700
Author(s):
CUI Jin - wei 1;  ZHANG Xiao - mei 2;  YANG Hua - sheng 3;  LAI Yu - xin 1;  LIU Yu - shan 1;  YU Xiao - lin 1;  JIANG Liang - duo 4
1.Beijing University of Chinese Medicine, Beijing 100029,China;
2. Department of Respiratory Febrile disease in Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078,China;
3. You??an Hospital Affiliated to Capital Medical University, Beijing 100069,China;
4. Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700,China
关键词:
新冠肺炎; 急性虚损; 顾护正气; 顾护宗气; 健脾益气; 益气养阴
Keywords:
COVID - 19;  Acute insufficiency;  Guard healthy Qi
分类号:
R256.1
DOI:
10.13424/j.cnki.jsctcm.2021.01.002
文献标志码:
A
摘要:
急性虚损是新冠肺炎发生发展的关键病机,主要表现为宗气虚导致的气不摄津,脾胃虚弱,湿邪弥漫以及恢复期肺脾两虚,气阴亏耗。在治疗中,姜老认为顾护正气贯穿始终,结合清热化湿解毒,可以避免内闭外脱等危候。具体从顾护宗气以摄津液、健脾益气以化湿浊、益气养阴以防复感着手进行治疗,用药特点有初期重用黄芪、人参,疾病进展期清热利湿药配伍太子参、西洋参等顾护气阴之品,内闭外脱期应用人参、山萸肉、西洋参、三七等。用党参、茯苓、白术、苍术、佩兰、白豆蔻、升麻、葛根之品,以健脾、醒脾、运脾、升阳达到健脾益气以化湿浊之功,疾病恢复期,健脾益气可选用党参、茯苓、白术、豆蔻、香橼、佛手等,养阴生津可选用沙参、石斛、玉竹、麦冬、芦根等药。
Abstract:
Acute insufficiency is a critical period in the progress of COVID - 19 which is characterized by the failing control of Qi over fuild, deficiency of spleen and stomach, pervasive dampness and deficiency of both lung and spleen as well as the depletion of both Qi and Yin occuring under recovery due to the insufficiency of pectoral Qi. In terms of the treatment, JIANG Liang - duo holds that consistent guard of healthy Qi plus heat - clearing and dampness - resolving as well as detoxication can avoid the hazard symptoms like inner blocking causing collapse etc. The specific treatment begins from guarding healthy Qi to control fluid, invigorating spleen and benefiting Qi to resolving dampness as well as benefiting Qi and maintain Yin to avoid the recurrent infection. At the onset, a large quantity of Huangqi and Renshen should be used. At the progressive stage, Taizishen and Xiyangshen, herbs which can guard Yin, are combined with medicine of heat - clearing and dampness - resolving. In the phase of inner blocking causing collapse, Renshen, Shanyurou, Xiyangshen, Sanqi are recommended. Dangshen, Fuling, Baizhu, Cangzhu, Peilan, Baidoukou, Shengma, Gegen can be used to invigorate, enliven and activate spleen as well as ascend Yang, strengthening spleen and resolving dampness finally. In the phase of recovery, Dangshen, Fuling, Baizhu,Doukou, Xiangyuan, Foshou are recommended to invigorate spleen and benefit Qi, while Shashen, Shihu, Yuzhu,Maidong, Lugen can maintain Yin.

参考文献/References:

[1]WANGDW,HUB,HUC,ETAL. Clinical characteristic of 138 hospitalized patient with 2019 Novel Coronavirus Infected Pneumonia in Wuhan, China. [J/OL].(2020-02-07)[2020-02-13]JAMA,2020.https://jamanetwork.com/journals/jama/fullarticle/2761044.
[2]姜良铎.中医急诊学(新世纪第二版)[M].北京:中国中医药出版社,2007:1-2.
[3]岳冬辉.中医疫病病因学理论探析[J].中华中医药杂志,2012,27(12):3044-3047.
[4]肖群益,刘林.杨栗山《伤寒瘟疫条辨》学术思想源流探讨[J].中华中医药杂志,2016,31(4):1256-1258.
[5]高学理.《黄帝内经》宗气理论及其临床意义[D].郑州:河南中医药大学,2018.
[6]杨华升,王兰,姜良铎.姜良铎从“气不摄津”认识新型冠状病毒肺炎[J/OL].中医杂志:1-4[2020-03-29].http://kns.cnki.net/kcms/detail/11.2166.R.20200202.1407.002.html.
[7]刘茜,屈国强.新型冠状病毒肺炎死亡尸体系统解剖大体观察报告[J].法医学杂志.2020,36(1):19-21.
[8]新型冠状病毒肺炎诊疗方案(试行第七版)[J].传染病信息,2020,33(1):1-6+26.
[9]王玉光,齐文升,马家驹,等.新型冠状病毒肺炎中医临床特征与辨证治疗初探[J].中医杂志,2020,61(4):281-285.
[10]杨华升,李丽等北京地区新型冠状病毒肺炎中医证候及病机特点初探[J/OL].北京中医药:1-7[2020-03-29].http://kns.cnki.net/kcms/detail/11.5635.r.20200212.2218.002.html.
[11]杨华升,王兰,姜良铎.姜良铎教授防治新型冠状病毒肺炎遣方用药思路[J/OL].中国实验方剂学杂志:1-6[2020-03-15].https://doi.org/10.13422/j.cnki.syfjx.20200840.
[12]张璐砾,戴铭,黄贵华,等.近代名医陈务斋治疫学术思想探析[J].中华中医药杂志,2019,34(3):1150-1152.

相似文献/References:

[1]杨璞叶,黄小正,杨明博,等.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(预出版):024.
　Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):024.
[2]魏耕树 朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(预出版):036.
　Gengshu Wei,Enlin Zhu,Xin Wang,et al.Feasibility of Yiqi Xuanbi Decoctionin treating pulmonary fibro - sisafter new crown pneumonia[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):036.
[3]赵晓平 昝强 范小璇** 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式**[J].陕西中医药大学学报,2020,(预出版):061.
　Xiaoping Zhao,Qiang Zan,Xiaoxuan Fan*,et al.Follow the Pattern of 4+4 to Prevention and Control Novel Coronavirus Pneumonia(NCP) in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):061.
[4]赵晓平 昝强 范小璇 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式[J].陕西中医药大学学报,2020,(02):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
　Zhao Xiaoping,Zan Qiang,Fan Xiaoxuan,et al.The 4 +4 Pattern to Prevent and Control Coronavirus Disease 2019 in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
[5]杨璞叶 黄小正 杨明博 张鑫.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(03):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
　Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
[6]魏耕树朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(5):007.[doi:10.13424/j.cnki.jsctcm.2020.05.002]
　Wei Gengshu,Zhu Enlin,Wang Xin,et al.Feasibility of Yiqi Xuanbi Decoction in the Treatment of Post - Covid19 Pulmonary Fibrosis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):007.[doi:10.13424/j.cnki.jsctcm.2020.05.002]
[7]康艳 李耀辉** 薛敬东 刘伊莎.基于脏腑相关理论之肺脾相关分析新冠肺炎的病位[J].陕西中医药大学学报,2021,44(03):005.[doi:10.13424/j.cnki.jsctcm.2021.03.002]
[8]曹雪 蒲秀玲 刘小莹 彭红侠 郭团茂 张晓妮.陕西咸阳地区新型冠状病毒肺炎患者中医临床特征分析[J].陕西中医药大学学报,2021,44(04):001.[doi:10.13424/j.cnki.jsctcm.2021.04.001]
　CAO Xue PU Xiuling LIU Xiaoying PENG Hongxia GUO Tuanmao ZHANG Xiaoni.Clinical Characteristics of COVID-19 Patientsin Xianyang District of Shaanxi[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(01):001.[doi:10.13424/j.cnki.jsctcm.2021.04.001]
[9]毛娅 崔翔 王晓玲 刘运磊 吴倩张洁.安康地区26例普通型新冠病毒肺炎患者恢复期中医辨治体会[J].陕西中医药大学学报,2021,44(04):005.[doi:10.13424/j.cnki.jsctcm.2021.04.002]
　MAO Ya CUI XiangWANG Xiaoling LIU YunleiWU Qian ZHANG Jie.Experience in Treating 26 cases of CommonCOVID-19 Patients in Convalescence in Ankang area[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(01):005.[doi:10.13424/j.cnki.jsctcm.2021.04.002]
[10]王凤霞 张云 李晓彬 侯海荣 刘可春.小青龙汤用于新冠肺炎患者救治可行性分析[J].陕西中医药大学学报,2021,44(04):011.[doi:10.13424/j.cnki.jsctcm.2021.04.003]

备注/Memo

备注/Memo:
基金项目:2020年度北京中医药大学基本科研业项目(新冠肺炎防控应急专项)(2020-JYB-YJ—011)
通讯作者:张晓梅,博士,主任医师,博士生导师。 E-mail:zhangxim6767@sina.Com
更新日期/Last Update: 2021-01-19